Literature DB >> 24613966

[Immune thrombocytopenia -- onkopedic guidelines update: recommendations of a joint working group of the DGHO, ÖGHO, SGH + SSH and GPOH].

Axel Matzdorff1, Wolfgang Eberl, Aristoteles Giagounidis, Paul Imbach, Ingrid Pabinger, Bernhard Wörmann.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24613966     DOI： 10.1159/000356910

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN： 2296-5270            Impact factor:   2.825


× No keyword cloud information.
  3 in total

1.  Bidirectional inefficacy or intolerability of thrombopoietin receptor agonists: new data and a concise review.

Authors:  Fabian Depré; Nasra Aboud; Beate Mayer; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2017-01-25       Impact factor: 3.443

2.  Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia.

Authors:  Carina Hillgruber; Birgit Pöppelmann; Carsten Weishaupt; Annika Kathrin Steingräber; Florian Wessel; Wolfgang E Berdel; J Engelbert Gessner; Benoît Ho-Tin-Noé; Dietmar Vestweber; Tobias Goerge
Journal:  J Exp Med       Date:  2015-07-13       Impact factor: 14.307

3.  Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.

Authors:  Fabian Depré; Nasra Aboud; Beate Mayer; Abdulgabar Salama
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.